{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "#iterate through 100 encounters\n",
    "#extract notes\n",
    "# iterate through possible diagnoses\n",
    "# ask RAG model if diagnosis is present\n",
    "# store result in labled encounters df with column for each diagnosis\n",
    "\n",
    "#get encounter diagnosis and store in a column\n",
    "#get extract diagnosis and store in a column\n",
    "#save to csv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from dotenv import load_dotenv\n",
    "import os\n",
    "from query import DataLoader as dl\n",
    "from pathlib import Path\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "groq = os.getenv(\"groqkey\")\n",
    "data_path = '../Data'\n",
    "\n",
    "\n",
    "dl = dl(Path(data_path))\n",
    "\n",
    "data = dl.get_labled_encounters()\n",
    "encounter_keys = data['EncounterKey'].tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/reedevans/Documents/mids/DataSci210_MedicationDeprescriber/src/extraction.py:16: LangChainDeprecationWarning: The class `HuggingFaceEmbeddings` was deprecated in LangChain 0.2.2 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-huggingface package and should be used instead. To use it run `pip install -U :class:`~langchain-huggingface` and import as `from :class:`~langchain_huggingface import HuggingFaceEmbeddings``.\n",
      "  embeddings = HuggingFaceEmbeddings(model_name=\"NeuML/pubmedbert-base-embeddings\")\n",
      "/Library/Frameworks/Python.framework/Versions/3.12/lib/python3.12/site-packages/sentence_transformers/cross_encoder/CrossEncoder.py:13: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from tqdm.autonotebook import tqdm, trange\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "D00F3A8D5F43B2\n",
      "ICU Stress Ulcer Prophylaxis\n",
      "yes. \n",
      "\n",
      "the patient is receiving pantoprazole 40 mg iv daily, which is a common medication used for icu stress ulcer prophylaxis.\n",
      "\n",
      "Complete Prompt:\n",
      "System: You are a knowledgeable medical provider who specializes in medication management. \n",
      "        Given the patient notes unless hemodynamically unstable or new localizing sx pending CT A/P read  Dx:   - Blood Culture 09/03/21 - No growth to date  - UA unremarkable   - CXR without evidence of consolidation  - MRSA negative   - Deferring antibiotics at this time     #LLE proximal DVT  #Long-term Anticoagulation  Patient with acute onset LLE edema x3 days with US of Left leg at ***** notable for DVT extending from \" Left common femoral vein to popliteal vein. Risk factors include stasis (long car ride decreased mobility) and underlying malignancy.  Confirmed on repeat US DVT and CT Venogram which r/o tumor emboli. ***** likely need at least 3 months of OP AC.   - On lovenox now (September 05 - ) s/p heparin ggt   - plan to transition to ***** prior to DC    #Normocytic Anemia   Hgb 13.5 on admission. Suspect likely ACD given known malignancy. Iron labs with elevated ferritin. No evidence of bleeding  - ***** 80s Iron 23 (l) Ferritin: 1000 (h) ***** low Tsat 10%  - follow up B12: pending    #Deconditioning - improving  Iso chronic pain and likely new malignancy. Transfers independently but is dependent on DME including scooter for mobilizing. Pt with good motivation engagement of PT/OT.   - cont PT/OT while admitted  - pain control to optimize engagement     Inpatient Bundle:  Code Status: Full Code  Level of Care: Acute   Diet: Regular Diet   Pain: as above   DVT ppx: lovenox   Bowel Reg: ***** ***** ***** Bisacodyl PRN  *****:  none  Access: picc  GI ppx: not indicated  CPO/Tele: none  PT/OT: ordered  *****: pending onc work-up possible initiation of chemo therapy       Current Inpatient Meds     Scheduled Meds:   0.9% sodium chloride flush  10-20 mL Intravenous Q12H SCH    0.9% sodium chloride flush  3 mL Intravenous Q12H SCH    ALPRAZolam  1 mg Oral Once    enoxaparin  1 mg/kg (Dosing Weight) Subcutaneous Q12H SCH    lidocaine  1 patch Topical Daily SCH    melatonin  10 mg Oral Daily At ***** *****    polyethylene glycol  17 g Oral BID    senna  17.2 mg Oral Daily At ***** *****     Continuous Infusions:      PRN Meds:.0.9% sodium chloride flush 0.9% sodium chloride flush 0.9% sodium chloride flush acetaminophen ALPRAZolam bisacodyL famotidine HYDROmorphone hydrOXYzine LORazepam oxyCODONE simethicone traZODone    ***** ***** MD    09/12/23  \"\n",
      "\n",
      "PALLIATIVE FOLLOW UP CONSULT NOTE       24 *****  No acute events overnight.    132 OME of PRN opioids in the last 24 hours (don't not include fentanyl patch)    Subjective  Patient feeling well today. States that the liquid pain medication that he gets makes him ***** up. Otherwise he is not nauseous throughout the day and has been tolerating liquids well. Feels like the pain is pretty well controlled. Really wants to have some chicken noodle soup feels like he needs to chew something. Does not want the chicken broth as he feels it's disgusting. Feels like he can tolerate pills just fine.     Scores:   Pain: 2  Anxiety: 0  Nausea/vomiting:1: 0  Colostomy output:  N/A    Vitals  Temp:  [36.6 °C (97.8 °F)-36.8 °C (98.2 °F)] 36.6 °C (97.8 °F)  Heart Rate:  [63-89] 89  *****Resp:  [16-18] 16  BP: (100-121)/(56-76) 100/56  SpO2:  [96 %-100 %] 99 %      Intake/Output Summary (Last 24 hours) at 09/26/2023 *****  Last data filed at 09/26/2023 *****  Gross per 24 hour   Intake 2744.41 ml   Output 4830 ml   Net -2085.59 ml       Pain Score: 7    Physical Exam  Gen: Laying comfortably in bed engaged and interactive  HEENT: MMM EOMI face symmetric  Pulm: normal work of breathing on room air  Abd: Soft obese tender to deep palpation  Neuro: A&Ox4 moving all extremities spontaneously EOMI PERRL  Psych: mood/affect congruent    Scheduled Meds:   0.9% sodium chloride flush  10-20 mL Intravenous Q12H SCH    0.9% sodium chloride flush  3 mL Intravenous Q12H SCH    ALPRAZolam  0.5 mg Oral Daily At ***** *****    cefepime  2000 mg Intravenous Q12H SCH    cholecalciferol (vitamin D3)  4000 Units Oral Daily SCH    enoxaparin  1 mg/kg (Dosing Weight) Subcutaneous Q12H SCH    fentaNYL  1 patch Transdermal Q72H    filgrastim-sndz  480 mcg Subcutaneous Daily SCH (PM)    furosemide  40 mg Intravenous Q AM SCH    lidocaine  1 patch Topical Daily SCH    loratadine  10 mg Oral Daily SCH    melatonin  10 mg Oral Daily At ***** ***** \"    metroNIDAZOLE  500 mg Intravenous Q8H SCH    pantoprazole  40 mg Intravenous Daily SCH     Continuous Infusions:   Adult TPN (custom) 65 mL/hr at 09/25/23 2242    fat emulsion (fish oil based) 500 mL (09/25/23 2242)     PRN Meds:   0.9% sodium chloride flush  10-20 mL Intravenous PRN    0.9% sodium chloride flush  3 mL Intravenous PRN    0.9% sodium chloride flush  30 mL Intravenous Once PRN    acetaminophen  1000 mg Oral Q8H PRN    bisacodyL  10 mg Rectal Daily PRN    famotidine  20 mg Oral Daily PRN    HYDROmorphone  1 mg Intravenous Q3H PRN    HYDROmorphone  4-8 mg Oral Q4H PRN    hydrOXYzine  10 mg Oral Q8H PRN    LORazepam  0.5 mg Intravenous Q4H PRN    naloxone  0.1 mg Intravenous Q1 Min PRN    prochlorperazine  10 mg Intravenous Q6H PRN    simethicone  80 mg Oral Q6H PRN    traZODone  50 mg Oral Bedtime PRN       Data    CBC        09/26/23  0424 09/25/23  0534   WBC 13.2***** 13.8*****   HGB 8.8***** 8.7*****   HCT 27.3***** 27.2*****   PLT ***** *****       Chem7        09/26/23  0424 09/25/23  0534   NA 131***** 131*****   ***** 4.1 3.8   CL 100***** 102   CO2 22 22   BUN 12 13   CREAT 0.46***** 0.45*****   GLU ***** *****       Electrolytes        09/26/23  0424 09/25/23  0534   CA 8.5 8.1*****   ***** 1.8 2.1   PO4 3.4  --        Liver Panel        09/26/23  0424 09/25/23  0534   AST 64***** 49*****   ALT 66***** 52   ALKP 142***** 139*****   TBILI 3.8***** 3.2*****       No results found.    Assessment and Recommendations    ***** hx of chronic low back pain f/t/h L femoral vein DVT and large retroperitoneal mass encasing IVC and abdominal aorta with biopsy c/f germ cell/testicular tumor c/b malignant SBO (managing medically) and elevated bili now with chemotherapy initiation this hospitalization.      Palliative care encounter  Assessment & Plan  #) Cancer pain: Severe cancer-related abd and back pain from tumor burden. Patient used 206 OME over the last 24h prior to initiation of fentanyl patch which has been relatively consistent while on the PCA. This would ***** with 72-145mcg/hr \" fentanyl patch. We will\n",
      "\n",
      "Problem: Discharge Planning - Adult  Goal: Knowledge of and participation in plan of care  Outcome: Progress within 12 hours     Problem: Anxiety Patient / Family / Caregiver - Adult  Goal: Alleviation of anxiety (Patient / Family / Caregiver)  Outcome: Progress within 12 hours     Problem: Coping Ineffective Patient / Family / Caregiver - Adult  Goal: Effective coping (Patient / Family / Caregiver)  Outcome: Progress within 12 hours     Problem: Pain  Acute / Chronic- Adult  Goal: Control of chronic pain  Outcome: Progress within 12 hours     Problem: Bleeding at ***** or Actual - Adult  Goal: Absence of impaired coagulation signs and symptoms / active bleeding  Outcome: Progress within 12 hours     Problem: GI Elimination Impaired - Adult  Goal: ***** of soft formed stool  Outcome: Progress within 12 hours     \"\n",
      "\n",
      "PALLIATIVE FOLLOW UP CONSULT NOTE       24 *****  No acute events. Patient vomited earlier this morning  24 Hour opioid usage:   PRN Dilaudid 4-8mg q4H (x1 4mg PO D = 16 OME)  PRN Dilaudid 1mg IV q4H (x3 = 3mg IV D = 60 OME + 95 from ***** (190 OME)  Total PRN OME: 206    Subjective  Feeling well today. Pain and nausea are well controlled. Feels like the nausea medication is working well. Feels like the pain medications are working well. He put the fentanyl patch on last night and has kept it on overnight.     Scores:   Pain: 3  Anxiety: 0  Nausea/vomiting:2: 0  Colostomy output:  N/A    Vitals  Temp:  [36.6 °C (97.9 °F)-37 °C (98.6 °F)] 36.6 °C (97.9 °F)  Heart Rate:  [77-94] 89  *****Resp:  [16-18] 16  BP: (114-120)/(65-76) 116/76  SpO2:  [98 %-99 %] 99 %      Intake/Output Summary (Last 24 hours) at 09/25/2023 *****  Last data filed at 09/25/2023 *****  Gross per 24 hour   Intake 5038.04 ml   Output 5525 ml   Net -486.96 ml       Pain Score: 4    Physical Exam  Gen: Laying comfortably in bed engaged and interactive  HEENT: MMM EOMI face symmetric  Pulm: normal work of breathing on room air  Abd: Soft distended tender to palpation  Neuro: A&Ox4 moving all extremities spontaneously EOMI PERRL  Psych: mood/affect congruent    Scheduled Meds:   0.9% sodium chloride flush  10-20 mL Intravenous Q12H SCH    0.9% sodium chloride flush  3 mL Intravenous Q12H SCH    ALPRAZolam  0.5 mg Oral Daily At ***** *****    cefepime  2000 mg Intravenous Q12H SCH    enoxaparin  1 mg/kg (Dosing Weight) Subcutaneous Q12H SCH    fentaNYL  1 patch Transdermal Q72H    [START ***** 09/26/2023] filgrastim-sndz  480 mcg Subcutaneous Daily SCH (PM)    furosemide  40 mg Intravenous Q AM SCH    lidocaine  1 patch Topical Daily SCH    melatonin  10 mg Oral Daily At ***** *****    mesna (MESNEX) 777 mg in sodium chloride 0.9 % 1058 mL infusion  300 mg/m2 (Order-Specific) Intravenous Q24H    metroNIDAZOLE  500 mg Intravenous Q8H SCH    \" pantoprazole  40 mg Intravenous Daily SCH     Continuous Infusions:   Adult TPN (custom) 65 mL/hr at 09/24/23 2232    Adult TPN (custom)      fat emulsion (fish oil based) Stopped (09/25/23 1032)    fat emulsion (fish oil based)       PRN Meds:   0.9% sodium chloride flush  10-20 mL Intravenous PRN    0.9% sodium chloride flush  3 mL Intravenous PRN    0.9% sodium chloride flush  30 mL Intravenous Once PRN    acetaminophen  1000 mg Oral Q8H PRN    bisacodyL  10 mg Rectal Daily PRN    famotidine  20 mg Oral Daily PRN    HYDROmorphone  1 mg Intravenous Q4H PRN    HYDROmorphone  4-8 mg Oral Q4H PRN    hydrOXYzine  10 mg Oral Q8H PRN    LORazepam  0.5 mg Intravenous Q4H PRN    naloxone  0.1 mg Intravenous Q1 Min PRN    prochlorperazine  10 mg Intravenous Q6H PRN    simethicone  80 mg Oral Q6H PRN    traZODone  50 mg Oral Bedtime PRN       Data    CBC        09/25/23  0534 09/24/23  0440   WBC 13.8***** 13.6*****   HGB 8.7***** 9.5*****   HCT 27.2***** 29.5*****   PLT ***** *****       Chem7        09/25/23  0534 09/24/23  0844   NA 131***** 133*****   ***** 3.8 4.1   ***** ***** *****   CO2 22 22   BUN 13 12   CREAT 0.45***** 0.49*****   GLU 103 92       Electrolytes        09/25/23  0534 09/24/23  0844   CA 8.1***** 8.0*****   ***** 2.1 2.2   PO4  --  2.7       Liver Panel        09/25/23  0534 09/24/23  0440   AST 49***** 58*****   ALT 52 56   ALKP 139***** 153*****   TBILI 3.2***** 3.7*****       No results found.    Assessment and Recommendations      ***** hx of chronic low back pain f/t/h L femoral vein DVT and large retroperitoneal mass encasing IVC and abdominal aorta with biopsy c/f germ cell/testicular tumor c/b malignant SBO (managing medically) and elevated bili now with chemotherapy initiation this hospitalization.     Palliative care encounter  Assessment & Plan  #) Cancer pain: Severe cancer-related abd and back pain from tumor burden. Patient used 206 OME over the last 24h which has been relatively consistent over the last few days. This would ***** with 72-145mcg/hr fentanyl patch. We \" will remain on the, determine if there is evidence of the specific condition.\n",
      "Human: Based on the provided notes, is there evidence of ICU Stress Ulcer Prophylaxis? Respond with a simple 'yes' or 'no', followed by a brief explanation.\n",
      "{'ICU_Stress_Ulcer_Prophylaxis': True}\n",
      "{'ICU_Stress_Ulcer_Prophylaxis': [Document(metadata={'deid_note_key': 'DA19ED998CC6C6', 'EncounterKey': 'D00F3A8D5F43B2', 'NoteDate': '2023-09-12', 'DepartmentSpecialty': 'Inpatient Nursing', 'ProviderSpecialty': 'UCSF', 'ProviderType': 'Resident', 'is_on_last_note_date': 0, 'key': 'D00F3A8D5F43B2', 'PtDischargeDate': '2023-09-30', 'discharge_text': None}, page_content='unless hemodynamically unstable or new localizing sx pending CT A/P read  Dx:   - Blood Culture 09/03/21 - No growth to date  - UA unremarkable   - CXR without evidence of consolidation  - MRSA negative   - Deferring antibiotics at this time     #LLE proximal DVT  #Long-term Anticoagulation  Patient with acute onset LLE edema x3 days with US of Left leg at ***** notable for DVT extending from \" Left common femoral vein to popliteal vein. Risk factors include stasis (long car ride decreased mobility) and underlying malignancy.  Confirmed on repeat US DVT and CT Venogram which r/o tumor emboli. ***** likely need at least 3 months of OP AC.   - On lovenox now (September 05 - ) s/p heparin ggt   - plan to transition to ***** prior to DC    #Normocytic Anemia   Hgb 13.5 on admission. Suspect likely ACD given known malignancy. Iron labs with elevated ferritin. No evidence of bleeding  - ***** 80s Iron 23 (l) Ferritin: 1000 (h) ***** low Tsat 10%  - follow up B12: pending    #Deconditioning - improving  Iso chronic pain and likely new malignancy. Transfers independently but is dependent on DME including scooter for mobilizing. Pt with good motivation engagement of PT/OT.   - cont PT/OT while admitted  - pain control to optimize engagement     Inpatient Bundle:  Code Status: Full Code  Level of Care: Acute   Diet: Regular Diet   Pain: as above   DVT ppx: lovenox   Bowel Reg: ***** ***** ***** Bisacodyl PRN  *****:  none  Access: picc  GI ppx: not indicated  CPO/Tele: none  PT/OT: ordered  *****: pending onc work-up possible initiation of chemo therapy       Current Inpatient Meds     Scheduled Meds:   0.9% sodium chloride flush  10-20 mL Intravenous Q12H SCH    0.9% sodium chloride flush  3 mL Intravenous Q12H SCH    ALPRAZolam  1 mg Oral Once    enoxaparin  1 mg/kg (Dosing Weight) Subcutaneous Q12H SCH    lidocaine  1 patch Topical Daily SCH    melatonin  10 mg Oral Daily At ***** *****    polyethylene glycol  17 g Oral BID    senna  17.2 mg Oral Daily At ***** *****     Continuous Infusions:      PRN Meds:.0.9% sodium chloride flush 0.9% sodium chloride flush 0.9% sodium chloride flush acetaminophen ALPRAZolam bisacodyL famotidine HYDROmorphone hydrOXYzine LORazepam oxyCODONE simethicone traZODone    ***** ***** MD    09/12/23  \"'), Document(metadata={'deid_note_key': 'D832A8C345B6B6', 'EncounterKey': 'D00F3A8D5F43B2', 'NoteDate': '2023-09-26', 'DepartmentSpecialty': 'Inpatient Nursing', 'ProviderSpecialty': 'UCSF', 'ProviderType': 'Resident', 'is_on_last_note_date': 0, 'key': 'D00F3A8D5F43B2', 'PtDischargeDate': '2023-09-30', 'discharge_text': None}, page_content='PALLIATIVE FOLLOW UP CONSULT NOTE       24 *****  No acute events overnight.    132 OME of PRN opioids in the last 24 hours (don\\'t not include fentanyl patch)    Subjective  Patient feeling well today. States that the liquid pain medication that he gets makes him ***** up. Otherwise he is not nauseous throughout the day and has been tolerating liquids well. Feels like the pain is pretty well controlled. Really wants to have some chicken noodle soup feels like he needs to chew something. Does not want the chicken broth as he feels it\\'s disgusting. Feels like he can tolerate pills just fine.     Scores:   Pain: 2  Anxiety: 0  Nausea/vomiting:1: 0  Colostomy output:  N/A    Vitals  Temp:  [36.6 °C (97.8 °F)-36.8 °C (98.2 °F)] 36.6 °C (97.8 °F)  Heart Rate:  [63-89] 89  *****Resp:  [16-18] 16  BP: (100-121)/(56-76) 100/56  SpO2:  [96 %-100 %] 99 %      Intake/Output Summary (Last 24 hours) at 09/26/2023 *****  Last data filed at 09/26/2023 *****  Gross per 24 hour   Intake 2744.41 ml   Output 4830 ml   Net -2085.59 ml       Pain Score: 7    Physical Exam  Gen: Laying comfortably in bed engaged and interactive  HEENT: MMM EOMI face symmetric  Pulm: normal work of breathing on room air  Abd: Soft obese tender to deep palpation  Neuro: A&Ox4 moving all extremities spontaneously EOMI PERRL  Psych: mood/affect congruent    Scheduled Meds:   0.9% sodium chloride flush  10-20 mL Intravenous Q12H SCH    0.9% sodium chloride flush  3 mL Intravenous Q12H SCH    ALPRAZolam  0.5 mg Oral Daily At ***** *****    cefepime  2000 mg Intravenous Q12H SCH    cholecalciferol (vitamin D3)  4000 Units Oral Daily SCH    enoxaparin  1 mg/kg (Dosing Weight) Subcutaneous Q12H SCH    fentaNYL  1 patch Transdermal Q72H    filgrastim-sndz  480 mcg Subcutaneous Daily SCH (PM)    furosemide  40 mg Intravenous Q AM SCH    lidocaine  1 patch Topical Daily SCH    loratadine  10 mg Oral Daily SCH    melatonin  10 mg Oral Daily At ***** ***** \"    metroNIDAZOLE  500 mg Intravenous Q8H SCH    pantoprazole  40 mg Intravenous Daily SCH     Continuous Infusions:   Adult TPN (custom) 65 mL/hr at 09/25/23 2242    fat emulsion (fish oil based) 500 mL (09/25/23 2242)     PRN Meds:   0.9% sodium chloride flush  10-20 mL Intravenous PRN    0.9% sodium chloride flush  3 mL Intravenous PRN    0.9% sodium chloride flush  30 mL Intravenous Once PRN    acetaminophen  1000 mg Oral Q8H PRN    bisacodyL  10 mg Rectal Daily PRN    famotidine  20 mg Oral Daily PRN    HYDROmorphone  1 mg Intravenous Q3H PRN    HYDROmorphone  4-8 mg Oral Q4H PRN    hydrOXYzine  10 mg Oral Q8H PRN    LORazepam  0.5 mg Intravenous Q4H PRN    naloxone  0.1 mg Intravenous Q1 Min PRN    prochlorperazine  10 mg Intravenous Q6H PRN    simethicone  80 mg Oral Q6H PRN    traZODone  50 mg Oral Bedtime PRN       Data    CBC        09/26/23  0424 09/25/23  0534   WBC 13.2***** 13.8*****   HGB 8.8***** 8.7*****   HCT 27.3***** 27.2*****   PLT ***** *****       Chem7        09/26/23  0424 09/25/23  0534   NA 131***** 131*****   ***** 4.1 3.8   CL 100***** 102   CO2 22 22   BUN 12 13   CREAT 0.46***** 0.45*****   GLU ***** *****       Electrolytes        09/26/23  0424 09/25/23  0534   CA 8.5 8.1*****   ***** 1.8 2.1   PO4 3.4  --        Liver Panel        09/26/23  0424 09/25/23  0534   AST 64***** 49*****   ALT 66***** 52   ALKP 142***** 139*****   TBILI 3.8***** 3.2*****       No results found.    Assessment and Recommendations    ***** hx of chronic low back pain f/t/h L femoral vein DVT and large retroperitoneal mass encasing IVC and abdominal aorta with biopsy c/f germ cell/testicular tumor c/b malignant SBO (managing medically) and elevated bili now with chemotherapy initiation this hospitalization.      Palliative care encounter  Assessment & Plan  #) Cancer pain: Severe cancer-related abd and back pain from tumor burden. Patient used 206 OME over the last 24h prior to initiation of fentanyl patch which has been relatively consistent while on the PCA. This would ***** with 72-145mcg/hr \" fentanyl patch. We will'), Document(metadata={'deid_note_key': 'D09D51D0E7EA12', 'EncounterKey': 'D00F3A8D5F43B2', 'NoteDate': '2023-09-28', 'DepartmentSpecialty': 'Inpatient Nursing', 'ProviderSpecialty': nan, 'ProviderType': 'Registered Nurse', 'is_on_last_note_date': 0, 'key': 'D00F3A8D5F43B2', 'PtDischargeDate': '2023-09-30', 'discharge_text': None}, page_content='Problem: Discharge Planning - Adult  Goal: Knowledge of and participation in plan of care  Outcome: Progress within 12 hours     Problem: Anxiety Patient / Family / Caregiver - Adult  Goal: Alleviation of anxiety (Patient / Family / Caregiver)  Outcome: Progress within 12 hours     Problem: Coping Ineffective Patient / Family / Caregiver - Adult  Goal: Effective coping (Patient / Family / Caregiver)  Outcome: Progress within 12 hours     Problem: Pain  Acute / Chronic- Adult  Goal: Control of chronic pain  Outcome: Progress within 12 hours     Problem: Bleeding at ***** or Actual - Adult  Goal: Absence of impaired coagulation signs and symptoms / active bleeding  Outcome: Progress within 12 hours     Problem: GI Elimination Impaired - Adult  Goal: ***** of soft formed stool  Outcome: Progress within 12 hours     \"'), Document(metadata={'deid_note_key': 'D2861DF0704BB7', 'EncounterKey': 'D00F3A8D5F43B2', 'NoteDate': '2023-09-25', 'DepartmentSpecialty': 'Inpatient Nursing', 'ProviderSpecialty': 'UCSF', 'ProviderType': 'Resident', 'is_on_last_note_date': 0, 'key': 'D00F3A8D5F43B2', 'PtDischargeDate': '2023-09-30', 'discharge_text': None}, page_content='PALLIATIVE FOLLOW UP CONSULT NOTE       24 *****  No acute events. Patient vomited earlier this morning  24 Hour opioid usage:   PRN Dilaudid 4-8mg q4H (x1 4mg PO D = 16 OME)  PRN Dilaudid 1mg IV q4H (x3 = 3mg IV D = 60 OME + 95 from ***** (190 OME)  Total PRN OME: 206    Subjective  Feeling well today. Pain and nausea are well controlled. Feels like the nausea medication is working well. Feels like the pain medications are working well. He put the fentanyl patch on last night and has kept it on overnight.     Scores:   Pain: 3  Anxiety: 0  Nausea/vomiting:2: 0  Colostomy output:  N/A    Vitals  Temp:  [36.6 °C (97.9 °F)-37 °C (98.6 °F)] 36.6 °C (97.9 °F)  Heart Rate:  [77-94] 89  *****Resp:  [16-18] 16  BP: (114-120)/(65-76) 116/76  SpO2:  [98 %-99 %] 99 %      Intake/Output Summary (Last 24 hours) at 09/25/2023 *****  Last data filed at 09/25/2023 *****  Gross per 24 hour   Intake 5038.04 ml   Output 5525 ml   Net -486.96 ml       Pain Score: 4    Physical Exam  Gen: Laying comfortably in bed engaged and interactive  HEENT: MMM EOMI face symmetric  Pulm: normal work of breathing on room air  Abd: Soft distended tender to palpation  Neuro: A&Ox4 moving all extremities spontaneously EOMI PERRL  Psych: mood/affect congruent    Scheduled Meds:   0.9% sodium chloride flush  10-20 mL Intravenous Q12H SCH    0.9% sodium chloride flush  3 mL Intravenous Q12H SCH    ALPRAZolam  0.5 mg Oral Daily At ***** *****    cefepime  2000 mg Intravenous Q12H SCH    enoxaparin  1 mg/kg (Dosing Weight) Subcutaneous Q12H SCH    fentaNYL  1 patch Transdermal Q72H    [START ***** 09/26/2023] filgrastim-sndz  480 mcg Subcutaneous Daily SCH (PM)    furosemide  40 mg Intravenous Q AM SCH    lidocaine  1 patch Topical Daily SCH    melatonin  10 mg Oral Daily At ***** *****    mesna (MESNEX) 777 mg in sodium chloride 0.9 % 1058 mL infusion  300 mg/m2 (Order-Specific) Intravenous Q24H    metroNIDAZOLE  500 mg Intravenous Q8H SCH    \" pantoprazole  40 mg Intravenous Daily SCH     Continuous Infusions:   Adult TPN (custom) 65 mL/hr at 09/24/23 2232    Adult TPN (custom)      fat emulsion (fish oil based) Stopped (09/25/23 1032)    fat emulsion (fish oil based)       PRN Meds:   0.9% sodium chloride flush  10-20 mL Intravenous PRN    0.9% sodium chloride flush  3 mL Intravenous PRN    0.9% sodium chloride flush  30 mL Intravenous Once PRN    acetaminophen  1000 mg Oral Q8H PRN    bisacodyL  10 mg Rectal Daily PRN    famotidine  20 mg Oral Daily PRN    HYDROmorphone  1 mg Intravenous Q4H PRN    HYDROmorphone  4-8 mg Oral Q4H PRN    hydrOXYzine  10 mg Oral Q8H PRN    LORazepam  0.5 mg Intravenous Q4H PRN    naloxone  0.1 mg Intravenous Q1 Min PRN    prochlorperazine  10 mg Intravenous Q6H PRN    simethicone  80 mg Oral Q6H PRN    traZODone  50 mg Oral Bedtime PRN       Data    CBC        09/25/23  0534 09/24/23  0440   WBC 13.8***** 13.6*****   HGB 8.7***** 9.5*****   HCT 27.2***** 29.5*****   PLT ***** *****       Chem7        09/25/23  0534 09/24/23  0844   NA 131***** 133*****   ***** 3.8 4.1   ***** ***** *****   CO2 22 22   BUN 13 12   CREAT 0.45***** 0.49*****   GLU 103 92       Electrolytes        09/25/23  0534 09/24/23  0844   CA 8.1***** 8.0*****   ***** 2.1 2.2   PO4  --  2.7       Liver Panel        09/25/23  0534 09/24/23  0440   AST 49***** 58*****   ALT 52 56   ALKP 139***** 153*****   TBILI 3.2***** 3.7*****       No results found.    Assessment and Recommendations      ***** hx of chronic low back pain f/t/h L femoral vein DVT and large retroperitoneal mass encasing IVC and abdominal aorta with biopsy c/f germ cell/testicular tumor c/b malignant SBO (managing medically) and elevated bili now with chemotherapy initiation this hospitalization.     Palliative care encounter  Assessment & Plan  #) Cancer pain: Severe cancer-related abd and back pain from tumor burden. Patient used 206 OME over the last 24h which has been relatively consistent over the last few days. This would ***** with 72-145mcg/hr fentanyl patch. We \" will remain on the')]}\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from extraction import llmAgent\n",
    "from pathlib import Path\n",
    "\n",
    "# Initialize the llm agent\n",
    "groq_key = groq\n",
    "data_path = Path(data_path)  # Set your data path\n",
    "agent = llmAgent(groq_key=groq_key, data_path=data_path)\n",
    "\n",
    "# Create empty DataFrame to store results\n",
    "columns = [\n",
    "    \"Mild to moderate esophagitis\",\n",
    "    \"GERD\",\n",
    "    \"Peptic Ulcer Disease\",\n",
    "    \"Upper GI symptoms\",\n",
    "    \"ICU Stress Ulcer Prophylaxis\",\n",
    "    \"Barretts Esophagus\",\n",
    "    \"Chronic NSAID use with bleeding risk\",\n",
    "    \"Severe esophagitis\",\n",
    "    \"Documented history of bleeding GI ulcer\",\n",
    "    \"H pylori infection\",\n",
    "]\n",
    "\n",
    "data = dl.get_labled_encounters()\n",
    "\n",
    "# Iterate through encounters (limiting to 100)\n",
    "for encounter_key in encounter_keys[:1]:\n",
    "    # Extract information from all three sources\n",
    "    # diagnosis_result, diagnosis_tokens = agent.extract_diagnosis(encounter_key)\n",
    "    # encounter_result, encounter_tokens = agent.extract_encounter_info(encounter_key)\n",
    "    print(encounter_key)\n",
    "    results, relevant_contexts = agent.extract_notes_individual(encounter_key)\n",
    "    print(results)\n",
    "    print(relevant_contexts)\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
